Ive got some simple stochastic modelling to share with y'all interested in the statistical apects of @Bioconlimited's trial of #Itolizumab. Bear with me while I put on my best Professorial air. Computer code and charts coming up, all in R.
Here is the Q. If A) the background mortality is 10% and I treat 'em all with 1 ml of pure saline. how many out of 20 wud die? Let's model this.
The proibability of observing 0 deaths in a sample of 20 patients each with a 10% probability of dying, from this simulation is:
Under the assumption that the long run background mortality risk = 10% then whatever we give to a sample of 20 patients we have a 12.5% chance of observing zero deaths. So if we give INR 40k worth of #Itoluzimab, p=12.5% that we shout Eureka! in error.
1. Whats the p value here.
A. In the simulation I had 1250 samples out of 10,000 in which there were exactly zero deaths. everybody had a 0.1 prob of dying.
P = 1250/10,000 = 0.125 = 12.5%.
Q How do you interpret this p value?